Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

Exosomes from rADSCs Stress-Preconditioned by Pathological Tissue Homogenate for Diabetic Wound Treatment.

Chen C., Zhang Z., Xu M., Yin X., Cao S., Pu X.

Animal Study on Diabetic Foot, Chronic Wound, published in ACS Biomater Sci Eng (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
ACS Biomater Sci Eng (2025)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
41269112
DOI
10.1021/acsbiomaterials.5c01711

Abstract (original English)

Diabetic wound healing is severely impaired by a pathological microenvironment, characterized by hyperinflammation, impaired angiogenesis, and disrupted ECM remodeling. Exosomes exhibit great potential for diabetic wound treatment, but the existing single-factor-stimulated exosomes often lack comprehensive reparative capabilities to simultaneously achieve matrix remodeling, inflammatory regulation, and angiogenesis. In this study, a multiple pathological preconditioning strategy using a diabetic wound homogenate (DWH) was developed to stimulate rat adipose-derived stem cells under stress, yielding exosomes (Aφ-exos) with enhanced multifaceted regenerative functions. Proteomic and miRNA sequencing revealed that A50-exos upregulated pro-healing factors (miR-21-5p, miR-126a-3p, HSP90, MMP9, etc.) and downregulated antihealing factors (miR-429, AGER, etc.) compared to those without DWH preconditioning (A0-exos). These multiple stress-preconditioned exosomes (A50-exos or A100-exos) synergistically enhanced fibroblast proliferation and migration, promoted M2 macrophage polarization, and improved endothelial angiogenesis under high-glucose conditions. When delivered via a GelMA hydrogel for sustained release, A50-exos or A100-exos significantly accelerated diabetic wound healing in vivo by enhancing collagen deposition, modulating inflammation, and stimulating vascularization. This bi

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
ExosomesAnimalsRatsWound HealingDiabetes Mellitus, ExperimentalMicroRNAsRats, Sprague-DawleyMaleCell ProliferationNeovascularization, Physiologic

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research